|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 157 studies with search of: | Atazanavir OR Reyataz[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
|
||||
| 2 | Recruiting |
Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
|
||||
| 3 | Recruiting |
Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects
|
||||
| 4 | Completed |
Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
|
||||
| 5 | Active, not recruiting |
Raltegravir and Atazanavir Dosing Strategy Study
|
||||
| 6 | Unknown † |
Atazanavir and Lamivudine for Treatment Simplification
|
||||
| 7 |
Completed
Has Results |
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
|
||||
| 8 | Recruiting |
Switch to Unboosted Atazanavir With Tenofovir Study
|
||||
| 9 | Completed |
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
|
||||
| 10 | Active, not recruiting |
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
|
||||
| 11 | Active, not recruiting |
PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
|
||||
| 12 |
Completed
Has Results |
Metabolic Effects of Switching Kaletra to Boosted Reyataz
|
||||
| 13 |
Completed
Has Results |
Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression
|
||||
| 14 | Active, not recruiting |
Safety and Efficacy of GS-9350-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 15 | Unknown † |
SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
|
||||
| 16 | Completed |
Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
|
||||
| 17 |
Completed
Has Results |
Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)
|
||||
| 18 | Completed |
Atazanavir Twice Daily
|
||||
| 19 | Completed |
Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
|
||||
| 20 | Unknown † |
Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|